18-hydroxy-19-norcorticosterone has been researched along with vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine- in 1 studies
Studies (18-hydroxy-19-norcorticosterone) | Trials (18-hydroxy-19-norcorticosterone) | Recent Studies (post-2010) (18-hydroxy-19-norcorticosterone) | Studies (vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-) | Trials (vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-) | Recent Studies (post-2010) (vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-) |
---|---|---|---|---|---|
9 | 0 | 0 | 357 | 5 | 22 |
Protein | Taxonomy | 18-hydroxy-19-norcorticosterone (IC50) | vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine- (IC50) |
---|---|---|---|
Vasopressin V1a receptor | Homo sapiens (human) | 0.0011 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujishima, M; Takata, Y; Takishita, S; Yamashita, Y | 1 |
1 other study(ies) available for 18-hydroxy-19-norcorticosterone and vasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(o- methyl-l-tyrosine)-8-l-arginine-
Article | Year |
---|---|
Lack of increase in sodium concentration of cerebrospinal fluid in DOCA-salt hypertensive rats.
Topics: 18-Hydroxycorticosterone; Adrenalectomy; Aldosterone; Animals; Arginine Vasopressin; Blood Pressure; Corticosterone; Hypertension; Rats; Rats, Inbred SHR | 1988 |